Ginger and Plasma Cholesterol Efflux Capacity

计划入组 35 人 · 首次发布于 2024 年 10 月 29 日

The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux

计划入组 86 人 · 首次发布于 2019 年 8 月 19 日

the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice

计划入组 200 人 · 首次发布于 2018 年 1 月 3 日

Cholesterol

C₂₇H₄₆O

Cholesterol sulfate

C₂₇H₄₆O₄S

cholesterol targeting therapeutic

Guangdong Jiaying Pharmaceutical Co.,Ltd.

China

ZyVersa Therapeutics to Present Kidney Disease Drug VAR 200 at JPM Healthcare Conference 2025

ZyVersa Therapeutics Initiates Phase 2a Trial for First-in-Class Diabetic Kidney Disease Treatment VAR 200

TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH